Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABHD15 antisense RNA 1 is a human long noncoding RNA gene, also referenced as linc-TP53I13 or lnc-TP53I13, located on chromosome 17. It is categorized as an antisense lncRNA to the ABHD15 protein-coding gene. While other lncRNAs in the p53 regulatory network play roles in transcriptional or post-transcriptional regulation influencing tumorigenesis or the cellular stress response, there is currently no evidence in the literature indicating a specific function, disease association, or role in drug response for ABHD15-AS1. No protein-coding function or therapeutic targeting has been reported for this transcript, and it is not implicated as a diagnostic or pharmacological biomarker.
Not applicable (no drugs targeting ABHD15-AS1 are documented).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ABHD15 antisense RNA 1 (ABHD15-AS1).